Core Viewpoint - The recent revision of the Anti-Unfair Competition Law aims to curb "involutionary competition" in the platform economy, which has led to unsustainable low prices and compromised product quality [1][2][3] Group 1: Involutionary Competition - Involutionary competition is characterized by platforms engaging in price wars to attract users, resulting in reduced product quality and increased pressure on merchants [1][2] - The law prohibits platform operators from forcing merchants to sell products below cost, signaling a shift towards rational competition [2][3] Group 2: Sustainable Low Prices - Sustainable low prices in the health market should be achieved through legitimate means such as technological innovation, economies of scale, and supply chain optimization, ensuring reasonable profits for merchants and real benefits for consumers [1][3] - The revision of the law is not aimed at banning low prices but at eliminating the distortion of price signals caused by involutionary competition, allowing merchants to focus on improving product quality [3]